149
http://www.DGS-PraxisLeitlinien.deNr.
Nachweis
318
Taylor D, Galan V, Weinstein SM, Reyes E, Pupo-Araya AR, Rauck R. Fentanyl pectin nasal
spray in breakthrough cancer pain. J Support Oncol 2010; 8(4): 184-190.
319
Tei Y, Morita T, Nakaho T, Takigawa C, Higuchi A, Suga A, Tajima T, Ikenaga M, Higuchi H,
Shimoyama N, Fujimoto M.Treatment efficacy of neural blockade in specialized palliative
care services in Japan: a multicenter audit survey. J Pain Symptom Manage 2008; 36(5):
461-467.
320
Tessaro L, Bandieri E, Costa G, Fornasier G, Iorno V, Pizza C, Pastacaldi G, Micheletto
G. Use of oxycodone controlled-release immediately after NSAIDs: a new approach to
obtain good pain control. Eur Rev Med Pharmacol Sci 2010; 14(2): 113-121.
321
Tester W, Ackler J, Tijani L, Leighton J. Phase I/II study of weekly docetaxel and vinblastine
in the treatment of metastatic hormone-refractory prostate carcinoma. Cancer J 2006;
12(4): 299-304.
322
Theiler R, Alon E, Brugger S, Ljutow A, Mietzsch T, Müller D, Ott A, Rimle M, Zemp
A,Urwyler A. Evaluation of a standardized internet-based and telephone-based patient
monitoring system for pain therapy with transdermal fentanyl. Clin J Pain 2007; 23(9):
804-811.
323
Townsend CO, Kerkvliet JL, Bruce BK, Rome JD, Hooten WM, Luedtke CA, Hodgson JE. A
longitudinal study of the efficacy of a comprehensive pain rehabilitation program with
opioid withdrawal: comparison of treatment outcomes based on opioid use status at
admission. Pain 2008; 140(1): 177-189.
324
Tsay SL, Chen HL, Chen SC, Lin HR, Lin KC. Effects of reflexotherapy on acute postope-
rative pain and anxiety among patients with digestive cancer. Cancer Nurs 2008; 31(2):
109-115.
325
Tschirner M, Ritzdorf I, Brunjes R. [Post marketing surveillance study with an analgesic
(transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
MMW Fortschr Med 2008; 150 Suppl 3: 142-148.
326
Ture H, Sayin M, Karlikaya G, Bingol CA, Aykac B, Ture U. The analgesic effect of gaba-
pentin as a prophylactic anticonvulsant drug on postcraniotomy pain: a prospective
randomized study. Anesth Analg 2009; 109(5): 1625-1631.
327
Ueberall MA, Mueller-Schwefe GH. Sublingual fentanyl orally disintegrating tablet in daily
practice: efficacy, safety and tolerability in patients with breakthrough cancer pain. Curr
Med Res Opin 2011; 27(7): 1385-1394.
328
Valeberg BT, Miaskowski C, Hanestad BR, Bjordal K, Moum T, Rustoen T. Prevalence rates
for and predictors of self-reported adherence of oncology outpatients with analgesic
medications. Clin J Pain 2008; 24(7): 627-636.
329
Valjus M, Ahonen J, Jokela R, Korttila K. Response Entropy is not more sensitive than
State Entropy in distinguishing the use of esmolol instead of remifentanil in patients
undergoing gynaecological laparoscopy. Acta Anaesthesiol Scand 2006; 50(1): 32-39.
330
van der Linden YM, Steenland E, van Houwelingen HC, Post WJ, Oei B, Marijnen CA, Leer
JW; Dutch Bone Metastasis Study Group. Patients with a favourable prognosis are equally
palliated with single and multiple fraction radiotherapy: results on survival in the Dutch
Bone Metastasis Study. Radiother Oncol 2006; 78(3): 245-253.
Literaturverzeichnis